HOME
ABOUT US
TECHNOLOGY PLATFORM
PIPELINE
NEWS
Company news
Conference & Exhibition
Industry Consulting
CONTACT
You are here: Home / Company news
09
2025-10
Sponsored by Exclcirc Biomed: 2025 SAPA Annual Meeting
Exclcirc (Suzhou) Biomedical Co., Ltd. participated in this 2025 SAPA Annual Meeting as a sponsor to contribute to industry exchanges and development.
05
2025-09
New Breakthrough in Organoids
Exclcirc (Suzhou) Biomedical Co., Ltd. has actively introduced an organoid technology platform.
14
2025-08
Exclcirc Biomed Summer Camp Concludes Successfully, Planting Seeds for the Future of Biomedicine
From August 5 to 14, 2025, during the prime summer vacation period, the \"Youth Experimental Training Summer Camp\" public welfare activity, carefully planned by Exclcirc (Suzhou) Biomedical Co., Ltd., was successfully held and concluded perfectly.
10
2025-07
Innovative circRNA Preparation Method Secures Chinese Patent, Boosting Expressive & Regulatory circRNA Development
The newly developed technology, entitled \"A Non-Residual Sequence Circular RNA Based on Ribozyme Self-Splicing and Its Preparation Method\" was granted a Chinese invention patent on June 27, 2025
01
2025-07
Embarking on a New Journey, Jointly Unfolding the Innovative Future of Biomedicine
Exclcirc Biomed\'s new office base at National Center of Technology Innovation for Biopharmaceuticals to Building A7, Zone I of Suzhou Industrial Park (BioBAY).
13
2025-03
Exclcirc (Suzhou) Biomedical Co., Ltd. has been granted a patent by the United States Patent and Trademark Office (USPTO).
Exclcirc (Suzhou) Biomedical Co., Ltd. has been granted a patent by the United States Patent and Trademark Office (USPTO) for its innovative method of synthesizing and preparing circRNA molecules.
20
2024-10
Exclcirc is announcing a new cooperation agreement
Exclcirc (Suzhou) Biomedical Co., Ltd. recently has officially signed a patent licensing agreement with the world\'s top 10 pharmaceutical company.
10
2024-10
Exclcirc has submitted a new Universal Scarless circRNA synthesis patent application
Exclcirc (Suzhou) Biomedical Co., Ltd. rewarded Notification of Passing Preliminary Examination of the Application for Invention from CNIPA on 8 Oct. 2024.
11
2024-07
New Award as Pioneering Scientist of Suzhou Industrial Park
Dr. Dai Dongsheng, Exclcirc (Suzhou) Biomedical Co., Ltd. has been selected as a Pioneering Scientist of Suzhou Industrial Park in 2024.
10
2024-06
A new pipeline for rare genetic diseases cooperated with Sir Run Run Shaw Hospital is on pre-clinical phage.
Exclcirc (Suzhou) Biomedical Co., Ltd. is developing a circular RNA based therapy for rare genetic diseases and cooperated with Sir Run Run Shaw Hospital.
19
2023-09
Exclcirc bursts into the final race of cell therapy project from NCTB
Congratulations to Exclcirc (Suzhou) Biomedical Co., Ltd. for bursting into final race in the project of cell therapy, launched by the National Biopharmaceutical Technology Innovation Center.
17
2023-05
Dr. Dai Dongsheng from our company has been selected as a leading talent for innovation and entrepreneurship in Shishan Science and Technology in Suzhou High tech Zone in 2023
The 2023 Shishan Technology Innovation and Entrepreneurship Leading Talents in Suzhou High tech Zone (the first batch of experts for centralized evaluation and the second batch of talent project roadshows) have undergone application, roadshows
Back to the top
Copyright © 2026 Exclcirc (Suzhou) Biomedical co.,Ltd All rights reserved
Back to the top